157 related articles for article (PubMed ID: 36275445)
1. Brain type of creatine kinase induces doxorubicin resistance via TGF-β signaling in MDA-MB-231 breast cancer cells.
Son S; Yoo SA; Nam K; Oh S; Lee KM; Yi JY; Shin I
Anim Cells Syst (Seoul); 2022; 26(5):203-213. PubMed ID: 36275445
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis.
Li XH; Chen XJ; Ou WB; Zhang Q; Lv ZR; Zhan Y; Ma L; Huang T; Yan YB; Zhou HM
Int J Biochem Cell Biol; 2013 May; 45(5):979-86. PubMed ID: 23416112
[TBL] [Abstract][Full Text] [Related]
3. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
4. ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells.
Wang F; Xiang Z; Huang T; Zhang M; Zhou WB
Cancer Manag Res; 2020; 12():9725-9734. PubMed ID: 33116832
[TBL] [Abstract][Full Text] [Related]
5. Fam96b recruits brain-type creatine kinase to fuel mitotic spindle formation.
Zhang XH; Chen XJ; Yan YB
Biochim Biophys Acta Mol Cell Res; 2023 Feb; 1870(2):119410. PubMed ID: 36503010
[TBL] [Abstract][Full Text] [Related]
6. Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes.
Alkaraki A; Alshaer W; Wehaibi S; Gharaibeh L; Abuarqoub D; Alqudah DA; Al-Azzawi H; Zureigat H; Souleiman M; Awidi A
Breast Cancer; 2020 Sep; 27(5):989-998. PubMed ID: 32328816
[TBL] [Abstract][Full Text] [Related]
7. RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis.
Chen J; Sun Y; Mao X; Liu Q; Wu H; Chen Y
J Biol Chem; 2010 Nov; 285(47):36315-21. PubMed ID: 20837480
[TBL] [Abstract][Full Text] [Related]
8. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
[TBL] [Abstract][Full Text] [Related]
9. HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy.
Krutilina RI; Playa H; Brooks DL; Schwab LP; Parke DN; Oluwalana D; Layman DR; Fan M; Johnson DL; Yue J; Smallwood H; Seagroves TN
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008190
[TBL] [Abstract][Full Text] [Related]
10. Expression of creatine kinase isoenzyme genes during postnatal development of rat brain cerebellum: evidence for transcriptional regulation.
Shen W; Willis D; Zhang Y; Schlattner U; Wallimann T; Molloy GR
Biochem J; 2002 Oct; 367(Pt 2):369-80. PubMed ID: 12093362
[TBL] [Abstract][Full Text] [Related]
11. Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.
Dumont N; Bakin AV; Arteaga CL
J Biol Chem; 2003 Jan; 278(5):3275-85. PubMed ID: 12421823
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of brain-type creatine kinase activity ameliorates neuronal deficits in Huntington's disease.
Lin YS; Cheng TH; Chang CP; Chen HM; Chern Y
Biochim Biophys Acta; 2013 Jun; 1832(6):742-53. PubMed ID: 23416527
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1, E2, and cholera toxin increase transcription of the brain creatine kinase gene in human U87 glioblastoma cells.
Kuzhikandathil EV; Molloy GR
Glia; 1995 Dec; 15(4):471-9. PubMed ID: 8926040
[TBL] [Abstract][Full Text] [Related]
14. Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
Al-Momany B; Hammad H; Ahram M
Curr Mol Pharmacol; 2021; 14(5):860-870. PubMed ID: 34061013
[TBL] [Abstract][Full Text] [Related]
15. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.
Lee YJ; Park JH; Oh SM
Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
Jayaraman S; Doucet M; Kominsky SL
Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.
Kakonen SM; Selander KS; Chirgwin JM; Yin JJ; Burns S; Rankin WA; Grubbs BG; Dallas M; Cui Y; Guise TA
J Biol Chem; 2002 Jul; 277(27):24571-8. PubMed ID: 11964407
[TBL] [Abstract][Full Text] [Related]
19. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells.
Yu W; Heim K; Qian M; Simmons-Menchaca M; Sanders BG; Kline K
Nutr Cancer; 1997; 27(3):267-78. PubMed ID: 9101557
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus glycoprotein B inhibits migration of breast cancer MDA-MB-231 cells and impairs TGF-β/Smad2/3 expression.
Yang R; Liang J; Xu GX; Ding LM; Huang HM; Su QZ; Yan J; Li YC
Oncol Lett; 2018 May; 15(5):7730-7738. PubMed ID: 29849800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
